Residency Program Director
  • Mike Boyd, PharmD, BCCP, BCPS

    • PGY2 Cardiology Residency Program Director, The Ohio State University Wexner Medical Center
    • Specialty Practice Pharmacist, Cardiology/Electrophysiology
    • Residency: Adult Medicine, St. Louis College of Pharmacy
    • PharmD: University of Cincinnati College of Pharmacy
Previous Year Residents
  • Anthony Ross, PharmD, BCPS

    CVICU Clinical Pharmacy Specialist - Cleveland Clinic
  • Jessica Brumit, PharmD, MBA, BCPS

    Cordiology Pharmacy Specialist - Johnson City Medical Center
  • Ryan Caputo, PharmD

    Staff Pharmacist, Indiana University Health, Indianapolis, IN
  • Kushal Naik, PharmD, MBA

    Clinical Pharmacist, CV ICU, Cleveland Clinic, Cleveland, OH
  • Rachel Klosko

    Clinical Assistant Faculty Member, Binghamton School of Pharmacy, Binghamton, New York
  • Rachael Eaton

    Clinical Pharmacy Specialist- Vascular Surgery, The Ohio State Wexner Medical Center
  • Rachel Lavelle

    Clinical Pharmacy Specialist – Cardiology, University of Chicago Medicine, Chicago, IL
  • Daniel Galipeau

    Cardiology Clinical Pharmacist, UK HealthCare, Lexington, Kentucky
  • Sara Johnson

    Cardiology Clinical Pharmacist, The University of Kansas Health System
  • Maya Holsen

    Cardiology Critical Care Specialty Pharmacist and Faculty, University of Buffalo
  • Joshua Jacobs

    Cardiology Clinical Pharmacist, The University of Utah
  • Shea Macielak

    Cardiothoracic Surgery Clinical Pharmacist, Mayo Clinic, Rochester, MN
  • Poonam Jewani

    Clinical Pharmacy Specialist, Cardiology, MD Anderson Cancer Center, Houston, TX
  • Brooke Stanton

    Clinical Specialist – Cardiology/Critical Care, SSM Health, St. Louis University Hospital, St. Louis, MO
  • Libby Orzel

    Medical Science Liaison, Sanofi
  • Christopher Min

    Medical Science Liaison, Sanofi
  • Heidi Brink

    Pharmacy Coordinator, Cardio/Pulmonary Transplant, Nebraska Medical Center
  • Bola Lawuyi

    Cardiology Clinical Specialist , Medstar Washington Hospital, Washington DC

About the PGY2 Cardiology Residency Program


PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Residency Sites

As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation iresearch, education, and patient care.

OSUWMC is a 1,506 bed multi-hospital delivery system recognized in 2018 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.

Read about the sites


The Ross Heart Hospital

The Richard M. Ross Heart Hospital at The OSUWMC is a 150-bed, comprehensive, cardiovascular center which specializes in the multidisciplinary care of patients in areas of  cardiovascular surgery, heart failure, pulmonary hypertension, heart and lung transplant , acute coronary syndromes, mechanical circulatory support  and electrophysiology. Each floor is dedicated to a specific service and combines the latest technology with patient –focused care to create the best possible healing environment. Our staff manages patients across a diverse spectrum of care, extending from critical care to the ambulatory setting.  Ohio State’s Heart and Vascular Center is considered one of the nation’s best hospitals for cardiology and heart surgery, as ranked by U.S. News & World Report, the only central Ohio hospital to earn a spot on the list. Our philosophy strongly supports working as a team to provide the right care to the right patient at the right time, in a safe and secure environment.



The OSUMC has many  opportunities for rounding on a cardiology-based service. The residents will be responsible for participation in clinical pharmacy rounding services with direct patient care responsibilities in a variety of settings. Most of the services are teaching services and may be composed of an attending physician, a fellow, and house staff (including residents, interns, and advanced practice providers). The resident will strengthen his/her clinical acumen and communication skills through completing at least one rotation on each required service. The remaining rotations will be determined based on the resident’s goals and the discretion of the residency program director.


Required Learning Experiences (4-5 weeks in duration unless noted otherwise):

  • General Cardiology
  • Acute Coronary Syndromes/Coronary Intensive Care
  • Heart Failure/Heart Transplant
  • Cardiovascular Intensive Care Unit
  • Thoracic Transplant
  • Electrophysiology (2 weeks)

Sample Elective Learning Experiences (2-5 weeks in duration):

  • Cardiovascular Ambulatory Care
  • Neurocritical Care
  • Advanced rotation in any of the required learning experiences

Key Preceptors

Danielle Blais, PharmD, BCCP, BCPS
Acute Coronary Syndrome/Coronary Intensive Care

Mike Boyd, PharmD, BCCP, BCPS
Electrophysiology/ Cardiology

Pam Burcham, PharmD, BCTXP, BCPS
Thoracic Transplant

Rachael Eaton, PharmD, BCCP
Vascular Surgery

Kevin Kissling, PharmD, BCPS
Heart Failure/Heart Transplant

Kerry Pickworth, PharmD, FCCP
Heart Failure/Heart Transplant

Alan Rozycki, PharmD, BCCCP
Cardiovascular Intensive Care Unit

Selected Resident Research

  • Incidence and time to cytomegalovirus disease in cardiac transplant recipients receving induction immunosuppression with antithymocyte globulin- Jewani P, Kissling K
  • Sotalol initiation in patients with a prolonged corrected QT interval:  experiences from an academic medical center- Stanton B, Boyd JM
  • Risk factors associated with subtherapeutic anticoagulation with Bivalirudin – Herman L
  • Switching From Ticagrelor to Clopidogrel: Outcomes after Percutaneous Coronary Intervention-Min C
  • Comparison of the safety of adenosine and regadenoson in outpatient cardiac stress testing. Pharmacother 2015;35(12):1117-1123.- Brink H, Dickerson J, Stephens J, Pickworth K
  • Desensitization as an approach to the clinical conundrum of cardiovascular patients with aspirin allergy-Lawuyi B, Blais D
  • Thirty day hospital readmission for thromboembolic complications in patients with potential heparin-induced thrombocytopenia- Kazmi H, Kissling K, Abel E
  • Efficacy of prophylactic oral amiodarone and intravenous magnesium in decreasing the incidence of post-operative atrial fibrillation in cardiac surgery- Varnado S, Burcham P, Blais D, Abel E

Benefits and Additional Requirements

Application Deadline:  January 2, 2021

We welcome applications from non-U.S. citizens who have a “green card” (permanent resident status) or a current visa valid through the entire duration of the residency program. The Ohio State University pharmacy residency programs are NOT able to sponsor visas for pharmacy residents (PGY1 or PGY2).

Start Date: July 1

Annual Salary – $50,500

Vacation Days – 10 days

Staffing Requirement – 20 weekends a year

Completion of a Major Research Project


Download PDF